Clinical Takeaways As the prevalence of obesity, insulin resistance, metabolic syndrome and associated health complications continue to rise, targeting GLP-1 activity has emerged as a promising strategy in improving cardiometabolic health and encouraging sustainable weight loss
The peaks are lower, so side effects should theoretically be milder
doi:10.2337/dc18-2028 Holman RR, Bethel MA, Mentz RJ, Thompson VP, Lokhnygina Y, Buse JB, et al
It's a powerhouse blend
By combining hormone replacement therapy with GLP-1 medications, youre addressing both the hormonal shifts and metabolic changes that drive weight gain during this transition
This is where we get into using peptides to optimize health, especially for those in their 30s and beyond